CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia

被引：0
|
作者：
Na Yang
Caili Zhang
Yingchun Zhang
Yuting Fan
Jing Zhang
Xiaojin Lin
Ting Guo
Yangzuo Gu
Jieheng Wu
Jianmei Gao
Xing Zhao
Zhixu He
机构：
[1] Guizhou Medical University (GMU),Tissue Engineering and Stem Cell Experiment Center
[2] Guizhou Medical University,Department of Immunology, College of Basic Medical Sciences
[3] Guizhou Medical University,Department of Biology, School of Basic Medical Sciences
[4] the Affiliated Hospital of Guizhou Medical University,Department of Gynecology
[5] Sichuan University,State Key Laboratory of Biotherapy and Cancer Center
[6] Zunyi Medical University,School of Pharmacy
[7] Chinese Academy of Medical Sciences),Key Laboratory of Adult Stem Cell Translational Research
[8] the Affiliated Hospital of Zunyi Medical University,Department of Pediatrics
来源：
Journal of Translational Medicine | / 22卷
关键词：
Chimeric antigen receptor; Natural killer cells; Dual targets; mRNA; Acute lymphoblastic leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
    Yang, Na
    Zhang, Caili
    Zhang, Yingchun
    Fan, Yuting
    Zhang, Jing
    Lin, Xiaojin
    Guo, Ting
    Gu, Yangzuo
    Wu, Jieheng
    Gao, Jianmei
    Zhao, Xing
    He, Zhixu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells
    Schneider, Dina
    Xiong, Ying
    Wu, Darong
    Nolle, Volker
    Schmitz, Sarah
    Kaiser, Andrew
    Dropulic, Boro
    Orentas, Rimas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S209 - S210
  • [3] Lentivirally and Alpharetrovirally Engineered CD19specific Chimeric Antigen Receptor Natural Killer Cells are Highly Cytotoxic against Acute Lymphoblastic Leukemia
    Bexte, Tobias
    Mueller, Stephan
    Gebel, Veronika
    Kalensee, Franziska
    Stolzenberg, Eva
    Hartmann, Jessica
    Koehl, Ulrike
    Schambach, Axel
    Winfried, Wels S.
    Modlich, Ute
    Ullrich, Evelyn
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 262 - 262
  • [4] Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center
    Zhu, Fenlu
    Shah, Nirav
    Xu, Huiqing
    Schneider, Dina
    Orentas, Rimas
    Dropulic, Boro
    Hari, Parameswaran
    Keever-Taylor, Carolyn A.
    CYTOTHERAPY, 2018, 20 (03) : 394 - 406
  • [5] High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
    Mueller, Stephan
    Bexte, Tobias
    Gebel, Veronika
    Kalensee, Franziska
    Stolzenberg, Eva
    Hartmann, Jessica
    Koehl, Ulrike
    Schambach, Axel
    Wels, Winfried S.
    Modlich, Ute
    Ullrich, Evelyn
    FRONTIERS IN IMMUNOLOGY, 2020, 10
  • [6] High cytotoxic efficiency of alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells for treatment of acute lymphoblastic leukemia
    Mueller, Stephan
    Bexte, Tobias
    Heinze, Annekathrin
    Schenk, Franziska
    Schambach, Axel
    Wels, Winfried S.
    Modlich, Ute
    Ullrich, Evelyn
    BONE MARROW TRANSPLANTATION, 2019, 54 : 293 - 294
  • [7] Phase 1 trial of CD19/CD20 bispecific chimeric antigen receptor-engineered naive/memory T cells for relapsed or refractory non-Hodgkin lymphoma
    Puliafito, Benjamin R.
    Walthers, Christopher
    Ji, Brenda
    Ghafouri, Sanaz N.
    Naparstek, Jacob
    Trent, Jacqueline
    Chen, Jia M.
    Roshandell, Mobina
    Harris, Caitlin
    Khericha, Mobina
    Schweppe, Thomas
    Berent-Maoz, Beata
    Gosliner, Stanley B.
    Almaktari, Amr
    Ceja, Melanie Ayala
    Allen-Auerbach, Martin S.
    Said, Jonathan
    Nawaly, Karla
    Mead, Monica
    de Vos, Sven
    Young, Patricia A.
    Oliai, Caspian
    Schiller, Gary J.
    Timmerman, John M.
    Ribas, Antoni
    Chen, Yvonne Y.
    Larson, Sarah M.
    CANCER RESEARCH, 2023, 83 (08)
  • [8] Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
    Zu, Yingling
    Ren, Quan
    Zhang, Jishuai
    Su, Hongchang
    Lu, Qiumei
    Song, Yongping
    Zhou, Jian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [9] Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
    Sisi Wang
    Lijun Peng
    Wenqian Xu
    Yuebo Zhou
    Ziyan Zhu
    Yushan Kong
    Stewart Leung
    Jin Wang
    Xiaoqiang Yan
    Jian-Qing Mi
    Frontiers of Medicine, 2022, 16 : 139 - 149
  • [10] Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
    Wang Sisi
    Peng Lijun
    Xu Wenqian
    Zhou Yuebo
    Zhu Ziyan
    Kong Yushan
    Leung Stewart
    Wang Jin
    Yan Xiaoqiang
    Mi JianQing
    Frontiers of Medicine, 2022, 16 (01) : 139 - 149
12345